| (Loss) Earnings per Share |
(Loss) Earnings per Share Basic earnings (loss) per share (“EPS”) is computed using the weighted average number of shares of common stock outstanding during the period. For periods presented with net losses, diluted net loss per share is the same as basic net loss per share because the inclusion of all potentially dilutive shares of common stock would have been anti-dilutive. For the six months ended September 30, 2021, diluted EPS reflects the incremental shares issuable upon the assumed exercise of stock options and equity awards. The following table reflects the calculation of basic and diluted EPS:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | | (in millions, except per-share amounts) | | September 30, 2021 | | September 30, 2020 | | September 30, 2021 | | September 30, 2020 | | Net (loss) income attributable to DXC common shareholders: | | $ | (188) | | | $ | (244) | | | $ | 90 | | | $ | (449) | | | | | | | | | | | | Common share information: | | | | | | | | | | Weighted average common shares outstanding for basic EPS | | 252.40 | | | 254.13 | | | 253.53 | | | 253.88 | | | Dilutive effect of stock options and equity awards | | — | | | — | | | 5.37 | | | — | | | Weighted average common shares outstanding for diluted EPS | | 252.40 | | | 254.13 | | | 258.90 | | | 253.88 | | | | | | | | | | | | (Loss) earnings per share: | | | | | | | | | | Basic | | $ | (0.74) | | | $ | (0.96) | | | $ | 0.35 | | | $ | (1.77) | | | Diluted | | $ | (0.74) | | | $ | (0.96) | | | $ | 0.35 | | | $ | (1.77) | |
Certain share-based equity awards were excluded from the computation of dilutive EPS because inclusion of these awards would have had an anti-dilutive effect. The number of awards excluded were as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | | | September 30, 2021(1) | | September 30, 2020(1) | | September 30, 2021 | | September 30, 2020(1) | | Stock Options | | 745,357 | | | 1,625,591 | | | 521,967 | | | 1,735,395 | | | Restricted Stock Units | | 1,990,916 | | | 2,598,301 | | | 205,014 | | | 2,554,090 | | | Performance Stock Units | | 2,829,237 | | | 83,125 | | | 1,309,752 | | | 158,444 | | | | | | | | | | |
(1) Due to the Company’s net losses for the three months ended September 30, 2021 and the three and six months ended September 30, 2020, stock options, restricted stock units and performance stock units were excluded from the computation of dilutive EPS because they would have had an anti-dilutive effect.
|